AnPac Bio-Medical Science Co., Ltd.（ANPC）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ANPC · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-12	2021-12	2020-12	2019-12	2018-12
Revenue
Revenue	$12.04M	$17.99M	$20.51M	$10.85M	$10.25M
Cost of Revenue	$3.71M	$5.73M	$7.63M	$6.05M	$5.67M
Gross Profit	$8.34M	$12.25M	$12.88M	$4.80M	$4.58M
Gross Margin %(computed)	69.21%	68.13%	62.81%	44.24%	44.66%
Operating Expenses
R&D Expenses	$9.53M	$16.20M	$11.58M	$9.84M	$10.11M
G&A Expenses	$70.79M	$80.68M	$74.76M	$70.78M	$28.85M
Total Operating Expenses	$92.47M	$118.30M	$106.01M	$93.88M	$48.19M
Operating Income	($84.14M)	($106.05M)	($93.13M)	($89.08M)	($43.61M)
Operating Margin %(computed)	-698.59%	-589.60%	-454.07%	-821.41%	-425.45%
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$0.37M	$4.26M	$1.14M	$2.61M	$0.93M
Income Before Tax	($105.73M)	($121.27M)	($80.65M)	($101.84M)	($42.49M)
Income Tax Expense	($2.13M)	($1.18M)	($0.09M)	($0.22M)	($0.20M)
Net Income	($103.60M)	($120.09M)	($80.56M)	($101.62M)	($42.06M)
Net Margin %(computed)	-860.16%	-667.67%	-392.83%	-937.03%	-410.37%
Per Share & EBITDA
EPS (Basic)	$-54.18	$-176.53	$-143.99	$-205.96	$-3.76
Wtd Avg Shares	1.91M	0.68M	0.56M	0.49M	11.20M
EBITDA	($99.62M)	($112.10M)	($77.41M)	($93.35M)	($38.19M)
EBITDA Margin %(computed)	-827.12%	-623.25%	-377.46%	-860.74%	-372.61%